TWI743939B - Blood processing filter - Google Patents

Blood processing filter Download PDF

Info

Publication number
TWI743939B
TWI743939B TW109127422A TW109127422A TWI743939B TW I743939 B TWI743939 B TW I743939B TW 109127422 A TW109127422 A TW 109127422A TW 109127422 A TW109127422 A TW 109127422A TW I743939 B TWI743939 B TW I743939B
Authority
TW
Taiwan
Prior art keywords
filter
blood
ventilation resistance
filter layer
unit
Prior art date
Application number
TW109127422A
Other languages
Chinese (zh)
Other versions
TW202206130A (en
Inventor
中村和彥
橫溝朋久
Original Assignee
日商旭化成醫療股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商旭化成醫療股份有限公司 filed Critical 日商旭化成醫療股份有限公司
Priority to TW109127422A priority Critical patent/TWI743939B/en
Application granted granted Critical
Publication of TWI743939B publication Critical patent/TWI743939B/en
Publication of TW202206130A publication Critical patent/TW202206130A/en

Links

Images

Landscapes

  • External Artificial Organs (AREA)

Abstract

本發明之課題為提供一種在白血球去除性能、過濾時間(過濾速度)、及血液回收上皆優異的血液處理過濾器。前述課題可藉由下述血液處理過濾器解決。 The subject of the present invention is to provide a blood processing filter that is excellent in white blood cell removal performance, filtration time (filtration speed), and blood recovery. The aforementioned problems can be solved by the following blood processing filter.

一種血液處理過濾器,其係包含:血液之入口部及出口部之可撓性容器、配置於前述可撓性容器內的前述入口部與前述出口部之間的濾材、及配置於前述可撓性容器內的前述濾材與前述出口部之間的流路確保部件的血液處理過濾器,其特徵係:前述濾材,包含:包含過濾器構成單元A1之過濾層X1、包含過濾器構成單元B之過濾層Y;前述過濾層X1,配置於前述過濾層Y與前述流路確保部件之間;前述過濾器構成單元A1的每單位厚度之通氣阻力為5.0Pa.s/m2以上且未滿9.0Pa.s/m2; 前述過濾器構成單元B的每單位厚度之通氣阻力為9.0Pa.s/m2以上;前述過濾層X1的通氣阻力為4.0kPa.s/m以上且20.0kPa.s/m以下;前述濾材的通氣阻力為55.0kPa.s/m以上且未滿75.0kPa.s/m。 A blood processing filter comprising: a flexible container for an inlet and an outlet of blood, a filter material arranged between the inlet and the outlet in the flexible container, and a filter arranged on the flexible container The blood processing filter of a flow path ensuring member between the filter material and the outlet portion in a sexual container is characterized by: the filter material includes: a filter layer X1 including a filter configuration unit A1, and a filter configuration unit B The filter layer Y; the filter layer X1 is arranged between the filter layer Y and the flow path ensuring member; the ventilation resistance per unit thickness of the filter constituting unit A1 is 5.0Pa. s/m 2 or more and less than 9.0Pa. s/m 2 ; The ventilation resistance per unit thickness of the aforementioned filter constituting unit B is 9.0Pa. s/m 2 or more; the ventilation resistance of the aforementioned filter layer X1 is 4.0kPa. s/m or more and 20.0kPa. s/m or less; the ventilation resistance of the aforementioned filter material is 55.0kPa. s/m or more and less than 75.0kPa. s/m.

Description

血液處理過濾器 Blood processing filter

本發明係關於一種用於從含血液成分之液體或血液中去除凝集物或白血球等之不期望成分的血液處理過濾器。 The present invention relates to a blood processing filter for removing undesired components such as agglutinates or white blood cells from liquid or blood containing blood components.

本發明,特別係關於用於從輸血用之全血製劑、紅血球製劑、血小板製劑、血漿製劑等去除為副作用之原因之微小凝集物或白血球的血液處理過濾器。 The present invention particularly relates to a blood processing filter for removing microaggregates or white blood cells that are the cause of side effects from whole blood preparations, red blood cell preparations, platelet preparations, plasma preparations, etc. for blood transfusion.

在紅血球製劑、血小板製劑、血漿製劑等之血液成分製劑之原料,使用從捐贈者採血之全血時,全血中,會包含為各種輸血副作用之原因之微小凝集物或白血球等之不期望的成分。因此,一般而言,在採血後或使用血液成分製劑之前,會進行不期望成分的去除。 When whole blood collected from a donor is used as the raw material for blood component preparations such as red blood cell preparations, platelet preparations, and plasma preparations, the whole blood may contain undesirable micro-aggregates or white blood cells that are the cause of various blood transfusion side effects. Element. Therefore, in general, removal of undesirable components is carried out after blood collection or before the use of blood component preparations.

從全血或血液成分製劑去除白血球等之不期望成分的方法,基於操作簡便、成本低等,使用包含不織布等之纖維集合體或具有連續氣孔的多孔構造體等所製成之濾材的血液處理過濾器的過濾法係普及。 A method for removing undesired components such as white blood cells from whole blood or blood component preparations. Based on simple operation and low cost, blood treatment using a filter material made of a fibrous aggregate containing non-woven fabric or a porous structure with continuous pores, etc. The filtering method of the filter is popularized.

以往,血液處理過濾器,係廣泛使用將不織布或多孔質體所成濾材充填於聚碳酸酯等之硬質容器者,但由於容器的氣體通透性低,因此有難以適用作為採血分離裝置之滅菌步驟而被廣泛使用的蒸氣滅菌之 問題。此外,在封閉系統中,會有採血後先從全血製劑中去除白血球,再將血液處理過濾器切離後進行用於成分分離之離心分離操作的情形;或是藉由離心分離將全血分離為複數種血液成分後再進行白血球去除的情形,在後者的情形中,血液處理過濾器係與採血分離裝置一起被離心。此時,會有硬質的容器損傷袋或導管、硬質容器本身不耐受離心時之壓力而破損的可能性。 In the past, blood processing filters were widely used to fill hard containers such as polycarbonate with filter materials made of non-woven fabrics or porous bodies. However, due to the low gas permeability of the containers, it was difficult to apply as a sterilization device for blood sampling and separation. Step and the widely used steam sterilization problem. In addition, in a closed system, there may be cases in which leukocytes are removed from the whole blood preparation after blood collection, and then the blood processing filter is cut off and then centrifuged for component separation; or the whole blood is separated by centrifugation. In the case where leukocytes are removed after separation into a plurality of blood components, in the latter case, the blood processing filter is centrifuged together with the blood collection and separation device. At this time, the rigid container may damage the bag or catheter, and the rigid container itself cannot withstand the pressure during centrifugation and may be damaged.

作為解決此等問題點之方法,開發出將與採血分離裝置之袋所使用者相同或類似的可撓性且蒸氣通透性優異之素材使用於容器的「可撓性之血液處理過濾器」。 As a solution to these problems, we developed a "flexible blood processing filter" that uses materials that are the same as or similar to those used by the bag of the blood collection and separation device with flexibility and excellent vapor permeability. .

通常,以血液處理過濾器處理血液時,加入應處理的血液製劑,將藉由導管連接至過濾器之血液入口側的袋,置於高於過濾器20cm至100cm的位置,藉由重力之作用使血液製劑通過過濾器,並在藉由導管連接至過濾器之血液出口側的回收袋,收容過濾後之血液製劑。過濾的當中濾材的阻力會產生壓力損失,使過濾器入口側之空間變為正壓。由可撓性容器所成過濾器之情形下,由於容器為可撓性,會有此正壓導致容器膨脹為氣球狀,使濾材被擠到出口側之容器的傾向。 Generally, when the blood is processed by a blood processing filter, the blood preparation to be processed is added, and the bag connected to the blood inlet side of the filter by a catheter is placed at a position 20 cm to 100 cm higher than the filter, and gravity is applied. The blood preparation is passed through the filter, and the filtered blood preparation is contained in a recovery bag connected to the blood outlet side of the filter by a catheter. The resistance of the filter material in the filter will produce pressure loss, which makes the space on the inlet side of the filter become positive pressure. In the case of a filter made of a flexible container, since the container is flexible, there is a tendency for the positive pressure to cause the container to expand into a balloon shape, causing the filter material to be squeezed into the container on the outlet side.

此外,通常,會將用於收納以血液過濾器處理後之血液的袋置於低於過濾器50cm~100cm之位置,血液在重力之作用下移動到下流側之流路,導致過濾器之出口側表現呈負壓之傾向,可撓性容器容易密接於濾材。 In addition, usually, the bag used to store the blood processed by the blood filter is placed at a position 50cm~100cm lower than the filter, and the blood moves to the flow path on the downstream side under the action of gravity, resulting in the outlet of the filter The side exhibits a tendency of negative pressure, and the flexible container is easily attached to the filter material.

亦即,先前已指出:使用可撓性容器之過濾器,濾材經由雙重的力而密接於出口側容器的傾向強,因此會有血液的流動被阻礙而無 法得到充分之過濾流速及過濾性能的問題。 That is, it has been pointed out previously that the filter material using a flexible container has a strong tendency to adhere to the outlet side container through a double force, so the flow of blood will be hindered without being obstructed. Method to obtain sufficient filtration flow rate and filtration performance.

血球去除過濾器之性能,會被評價白血球去除性能、血液流動性、血液回收量,能否良好發揮其平衡係重要。然而,特別係白血球去除性能與血液流動性會基於上述理由使其在兼具上有問題。 The performance of the blood cell removal filter will be evaluated for the white blood cell removal performance, blood fluidity, and blood recovery volume. It is important that the balance can be exerted well. However, in particular, the leukocyte removal performance and blood fluidity have problems in both the above-mentioned reasons.

作為解決此問題之方法,專利文獻1開示了一種技術,其係藉由將流路確保片材作為流路確保部件配置在濾材與出口側容器之間,過濾中在出口側可撓性容器與濾材之間不密接而形成連續空隙,使過濾流速與白血球去除性能兼具。 As a method to solve this problem, Patent Document 1 discloses a technique in which a flow path securing sheet is arranged as a flow path securing member between the filter medium and the outlet side container, and the outlet side flexible container is connected to the outlet side container during filtration. The filter materials are not tightly connected to form a continuous gap, so that the filtration flow rate and the white blood cell removal performance are both.

此外,專利文獻2開示了一種技術,其係藉由將具有特定特性之過濾器構成要素所成的過濾層作為流路確保部件,以特定厚度配置在與出口側容器相接之濾材的最下流之位置,使過濾中濾材與出口側容器即使密接,該過濾層內仍會形成空隙,在該過濾層內藉由相對濾材厚度之垂直方向流動使其可為(較高)過濾流速。 In addition, Patent Document 2 discloses a technique in which a filter layer composed of filter components with specific characteristics is used as a flow path ensuring member, and the filter layer with a specific thickness is arranged at the lowest flow of the filter medium in contact with the outlet side container. The position ensures that even if the filter material is in close contact with the outlet side container, voids will still be formed in the filter layer, and the filter layer can flow in the vertical direction relative to the thickness of the filter material to achieve a (higher) filtration flow rate.

【先前技術文獻】【Prior Technical Literature】 【專利文獻】【Patent Literature】

【專利文獻1】日本專利第5524340號公報 [Patent Document 1] Japanese Patent No. 5524340

【專利文獻2】日本專利第4172631號公報 [Patent Document 2] Japanese Patent No. 4172631

專利文獻1中,由於流路確保部件本身不具有白血球去除性能,因此無法將白血球去除性能提高至最大上限。此外,流路確保片材會導致在流路或第一密封部與第二密封部之間殘留的血液,有增加被處理液之回收量損失的問題。 In Patent Document 1, since the flow path ensuring member itself does not have leukocyte removal performance, it is impossible to increase the leukocyte removal performance to the maximum upper limit. In addition, the flow path securing sheet may cause blood remaining in the flow path or between the first sealing part and the second sealing part, which increases the loss of the recovery volume of the liquid to be processed.

專利文獻2中,配置在與出口側容器相接之濾材之最下流位置的過濾層,一方面在濾材出口側與出口側之可撓性容器片材緊貼時在被壓縮下仍可在內部保持流路,但若為了使流動提升而增加過濾層(流路確保部件)量,會有被處理液之回收量損失增大的問題。此外,若使濾材量減少,白血球去除能降低,會有白血球去除性能、過濾流速、血液回收量無法同時皆以高性能發揮的問題。 In Patent Document 2, the filter layer arranged at the most downstream position of the filter medium connected to the outlet side container, on the one hand, when the filter medium outlet side and the outlet side of the flexible container sheet are in close contact with each other, it can still stay inside under compression. The flow path is maintained, but if the amount of the filter layer (flow path securing member) is increased in order to increase the flow, there will be a problem that the recovery volume loss of the liquid to be treated will increase. In addition, if the amount of filter material is reduced, the white blood cell removal performance is reduced, and there is a problem that the white blood cell removal performance, the filtration flow rate, and the blood recovery volume cannot all be achieved with high performance at the same time.

此等技術作為製品雖已達到可使用之等級,但在其平衡上仍有可改善之餘地。 Although these technologies have reached a usable level as products, there is still room for improvement in their balance.

本發明的課題,在於提供一種白血球去除性能、過濾時間(過濾速度)及血液回收皆優異的血液處理過濾器。 The subject of the present invention is to provide a blood processing filter with excellent white blood cell removal performance, filtration time (filtration speed), and blood recovery.

本發明人們,為了解決上述課題而深入研究,結果係發現:在血液的流動方向上,藉由使用在從上游往下游方向依序配置較細密之過濾層、較稀疏之過濾層、及流路確保部件的血液處理過濾器,可解決前述課題,從而完成本發明。 In order to solve the above-mentioned problems, the inventors have conducted in-depth research and found that in the direction of blood flow, a denser filter layer, a sparse filter layer, and a flow path are sequentially arranged in the direction from upstream to downstream. The blood processing filter that secures parts can solve the aforementioned problems, and thus the present invention has been completed.

亦即,本發明係關於以下所述者。 That is, the present invention relates to the following.

[1] [1]

一種血液處理過濾器,其係包含 具有血液之入口部及出口部之可撓性容器、配置於前述可撓性容器內的前述入口部與前述出口部之間的濾材、及配置於前述可撓性容器內的前述濾材與前述出口部之間的流路確保部件的血液處理過濾器,其特徵係前述濾材,包含包含過濾器構成單元A1之過濾層X1、包含過濾器構成單元B之過濾層Y;前述過濾層X1,配置於前述過濾層Y與前述流路確保部件之間;前述過濾器構成單元A1的每單位厚度之通氣阻力為5.0Pa.s/m2以上且未滿9.0Pa.s/m2;前述過濾器構成單元B的每單位厚度之通氣阻力為9.0Pa.s/m2以上;前述過濾層X1的通氣阻力為4.0kPa.s/m以上且20.0kPa.s/m以下;前述濾材的通氣阻力為55.0kPa.s/m以上且未滿75.0kPa.s/m。 A blood processing filter comprising a flexible container having an inlet and an outlet for blood, a filter material arranged between the inlet and the outlet in the flexible container, and a filter arranged in the flexible container The blood processing filter of the member for ensuring the flow path between the filter medium and the outlet portion in the sexual container is characterized in that the filter medium includes a filter layer X1 including a filter configuration unit A1, and a filter layer including a filter configuration unit B Y; The filter layer X1 is disposed between the filter layer Y and the flow path ensuring member; the ventilation resistance per unit thickness of the filter constituting unit A1 is 5.0Pa. s/m 2 or more and less than 9.0Pa. s/m 2 ; The ventilation resistance per unit thickness of the aforementioned filter constituting unit B is 9.0Pa. s/m 2 or more; the ventilation resistance of the aforementioned filter layer X1 is 4.0kPa. s/m or more and 20.0kPa. s/m or less; the ventilation resistance of the aforementioned filter material is 55.0kPa. s/m or more and less than 75.0kPa. s/m.

[2] [2]

如[1]所記載之血液處理過濾器,其中,前述流路確保部件係包含包含過濾器構成單元P之過濾層Z;前述過濾器構成單元P的每單位厚度之通氣阻力係未滿0.5Pa.s/m2;前述過濾層Z之通氣阻力為0.08kPa.s/m以上且0.16kPa.s/m以下。 The blood processing filter as described in [1], wherein the flow path ensuring member includes a filter layer Z including a filter constituent unit P; the ventilation resistance per unit thickness of the filter constituent unit P is less than 0.5 Pa . s/m 2 ; The ventilation resistance of the aforementioned filter layer Z is 0.08kPa. s/m or more and 0.16kPa. s/m or less.

[3] [3]

如[2]所記載之血液處理過濾器,其中,前述過濾層Z之通氣阻力為0.08kPa.s/m以上且0.12kPa.s/m以下。 The blood processing filter described in [2], wherein the ventilation resistance of the filter layer Z is 0.08kPa. s/m or more and 0.12kPa. s/m or less.

[4] [4]

如[1]~[3]中任一項所記載之血液處理過濾器,其中,前述濾材係進一步包含含有過濾器構成單元A2之過濾層X2;前述過濾層X2,配置於前述入口部與前述過濾層Y之間;前述過濾器構成單元A2的每單位厚度之通氣阻力為5.0Pa.s/m2以上且未滿9.0Pa.s/m2;前述過濾層X2的通氣阻力為4.0kPa.s/m以上。 The blood processing filter according to any one of [1] to [3], wherein the filter material further includes a filter layer X2 including a filter constituent unit A2; and the filter layer X2 is disposed at the inlet portion and the Between the filter layers Y; the ventilation resistance per unit thickness of the aforementioned filter constituting unit A2 is 5.0Pa. s/m 2 or more and less than 9.0Pa. s/m 2 ; The ventilation resistance of the aforementioned filter layer X2 is 4.0kPa. s/m or more.

藉由本發明,可提供一種白血球去除性能、過濾時間(過濾速度)及血液回收皆優異的血液處理過濾器。 According to the present invention, it is possible to provide a blood processing filter with excellent white blood cell removal performance, filtration time (filtration speed), and blood recovery.

【圖1】表示用於實施例中所實施之血液處理過濾器之白血球去除性能試驗之實驗裝置的概略圖。 [Fig. 1] A schematic diagram showing an experimental device used in the leukocyte removal performance test of the blood processing filter implemented in the embodiment.

以下,對用於實施本發明之型態(以下稱「本實施型態」)進行詳細說明。又,本發明並不受以下實施型態限定,可在其宗旨範圍內進行各種變形而實施。 Hereinafter, the mode for implementing the present invention (hereinafter referred to as "this embodiment mode") will be described in detail. In addition, the present invention is not limited to the following embodiments, and can be implemented with various modifications within the scope of its purpose.

以下,除非特別註明,「血液」之用語,係指包含含有血液及血液成分之液體者。含有血液成分之液體,例如,可列舉血液製劑。血液製劑,例如,可列舉全血製劑、紅血球製劑、血小板製劑、血漿製劑等。 Hereinafter, unless otherwise specified, the term "blood" refers to liquids containing blood and blood components. Examples of liquids containing blood components include blood preparations. Examples of blood preparations include whole blood preparations, red blood cell preparations, platelet preparations, and plasma preparations.

<血液處理過濾器> <Blood Processing Filter>

本發明一實施形態,係關於一種血液處理過濾器,其係包含具有血液之入口部及出口部之可撓性容器、配置於前述可撓性容器內的前述入口部與前述出口部之間的濾材、及配置於前述可撓性容器內的前述濾材與前述出口部之間的流路確保部件的血液處理過濾器,其特徵係前述濾材,包含包含過濾器構成單元A1之過濾層X1、包含過濾器構成單元B之過濾層Y;前述過濾層X1,配置於前述過濾層Y與前述流路確保部件之間;前述過濾器構成單元A1的每單位厚度之通氣阻力為5.0Pa.s/m2以上且未滿9.0Pa.s/m2;前述過濾器構成單元B的每單位厚度之通氣阻力為9.0Pa.s/m2以上;前述過濾層X1的通氣阻力為4.0kPa.s/m以上且20.0kPa.s/m以下;前述濾材的通氣阻力為55.0kPa.s/m以上且未滿75.0kPa.s/m。藉由採用如此構成,可在白血球去除性能、過濾速度及血液回收上皆發揮優異性能。 An embodiment of the present invention relates to a blood processing filter comprising a flexible container having an inlet and an outlet for blood, and a flexible container disposed between the inlet and the outlet in the flexible container A filter material, and a blood treatment filter of a flow path ensuring member between the filter material and the outlet portion arranged in the flexible container, characterized in that the filter material includes a filter layer X1 including a filter constituent unit A1, and includes The filter layer Y of the filter constituting unit B; the filter layer X1 is arranged between the filter layer Y and the flow path ensuring member; the ventilation resistance per unit thickness of the filter constituting unit A1 is 5.0Pa. s/m 2 or more and less than 9.0Pa. s/m 2 ; The ventilation resistance per unit thickness of the aforementioned filter constituting unit B is 9.0Pa. s/m 2 or more; the ventilation resistance of the aforementioned filter layer X1 is 4.0kPa. s/m or more and 20.0kPa. s/m or less; the ventilation resistance of the aforementioned filter material is 55.0kPa. s/m or more and less than 75.0kPa. s/m. By adopting such a structure, excellent performance in white blood cell removal performance, filtration speed, and blood recovery can be exerted.

本實施型態之血液處理過濾器中,從可撓性容器之入口部往出口部方向,係依序配置過濾層Y、過濾層X1、及流路確保部件。因此,需處理之血液,通過入口部而進入可撓性容器,依序通過過濾層Y、過濾層X1、及流路確保部件,並通過出口部而流出可撓性容器。 In the blood processing filter of this embodiment, the filter layer Y, the filter layer X1, and the flow path ensuring components are sequentially arranged from the inlet portion to the outlet portion of the flexible container. Therefore, the blood to be processed enters the flexible container through the inlet, sequentially passes through the filter layer Y, the filter layer X1, and the flow path ensuring member, and flows out of the flexible container through the outlet.

在不減損本發明之效果的範圍內,濾材可包含進一步的過 濾層。例如,理想係濾材進一步包含含有過濾器構成單元A2之過濾層X2。此外,過濾層X2,理想係配置於入口部與過濾層Y之間。此實施型態中,需處理之血液,通過入口部而進入可撓性容器,依序通過過濾層X2、過濾層Y、過濾層X1、及流路確保部件,並通過出口部而流出可撓性容器。 In the range that does not detract from the effect of the present invention, the filter material may include further filters. Filter layer. For example, the ideal filter medium further includes a filter layer X2 containing the filter constituent unit A2. In addition, the filter layer X2 is ideally arranged between the inlet portion and the filter layer Y. In this embodiment, the blood to be processed enters the flexible container through the inlet, passes through the filter layer X2, the filter layer Y, the filter layer X1, and the flow path ensuring components in sequence, and flows out of the flexible container through the outlet. Sex container.

本實施型態之血液處理過濾器之形狀雖無特別限制,理想係像例如國際公開第2015/050216號之圖14所記載的血液處理過濾器,由濾材與可撓性容器構成,具有遍及濾材之周緣部附近全周而與可撓性容器一體化的密封部區域;進一步地,理想係具有遍及濾材之周緣部附近全周與可撓性容器一體化的第一密封部區域、遍及第一密封區域之外側全周而使入口測可撓性容器與出口側可撓性容器一體化的第二密封區域、以及在第一密封區域與第二密封區域間的非密封區域。 Although the shape of the blood treatment filter of this embodiment is not particularly limited, it is ideally like the blood treatment filter described in Figure 14 of International Publication No. 2015/050216, which is composed of a filter material and a flexible container, and has a filter material throughout The entire circumference of the peripheral portion and the sealing portion area integrated with the flexible container; further, it is ideal to have a first sealing portion area that is integrated with the flexible container over the entire circumference of the filter material A second sealing area where the inlet flexible container and the outlet-side flexible container are integrated over the entire circumference of the outside of the sealing area, and an unsealed area between the first sealing area and the second sealing area.

血液處理過濾器之外形,可採用矩形狀、圓盤狀、長圓盤狀、橢圓狀等之各種態樣,由於製造時之材料損失較少因此矩形狀係理想,因此,以下之實施型態係以矩形狀為例而說明。 The outer shape of the blood processing filter can be rectangular, disc, oblong, elliptical, etc. Since the material loss during manufacturing is less, the rectangular shape is ideal. Therefore, the following implementation forms Take the rectangular shape as an example.

〔可撓性容器〕 〔Flexible container〕

可撓性容器,理想係由可撓性樹脂之片材狀成型物或圓柱狀成型物所成型的容器。可撓性樹脂,理想為可撓性合成樹脂,進一步理想係可撓性熱可塑性樹脂。可撓性樹脂,較佳係與濾材在熱性質及電性質上類似者。可撓性樹脂,可列舉例如軟質聚氯乙烯、聚氨酯、乙烯-乙酸聚乙烯共聚物、如聚乙烯及聚丙烯之聚烯烴、苯乙烯-丁二烯橡膠-苯乙烯共聚物之氫化物、苯乙烯-異戊二烯-苯乙烯共聚物或其氫化物等之熱可塑性彈性物, 以及,熱可塑性彈性物與聚烯烴、乙烯-丙烯酸乙酯等之軟化劑的混合物等。可撓性樹脂,理想為軟質聚氯乙烯、聚氨酯、乙烯-乙酸聚乙烯共聚物、聚烯烴、及以此等為主成分之熱可塑性彈性物,更理想係軟質聚氯乙烯、聚烯烴。此外,進一步理想係以拉伸彈性率為7N/mm2~13N/mm2、厚度為0.2mm~0.6mm之材所製作的可撓性容器。拉伸彈性率,係進行拉伸試驗時,拉伸應力(加在試樣上的每單位面積之負重)與應變(試樣之對拉伸方向之延伸率)之關係呈直線關係之範圍內,拉伸應力與對應此之應變的比。實際而言,係根據JISK 7113(塑膠之拉伸試驗方法),使用試驗機(autograph)(島津製作所(股)製,型號AG-5KNI)與測力器(島津製作所(股)製,型號SLBL-500N)進行可撓性容器素材之拉伸試驗,使用數據處理軟體「TRAPEZIUM」(島津製作所(股)製),藉由求出應力-應變曲線之變形起始點中接線之傾斜,得到拉伸彈性率。 The flexible container is preferably a container molded from a sheet-like molded object or a cylindrical molded object of a flexible resin. The flexible resin is preferably a flexible synthetic resin, and more preferably a flexible thermoplastic resin. The flexible resin is preferably one that is similar in thermal and electrical properties to the filter material. Flexible resins include, for example, soft polyvinyl chloride, polyurethane, ethylene-polyethylene acetate copolymers, polyolefins such as polyethylene and polypropylene, hydrogenated styrene-butadiene rubber-styrene copolymers, benzene Thermoplastic elastomers such as ethylene-isoprene-styrene copolymers or their hydrogenated products, and mixtures of thermoplastic elastomers with softeners such as polyolefins and ethylene-ethyl acrylate. The flexible resin is preferably soft polyvinyl chloride, polyurethane, ethylene-polyethylene acetate copolymer, polyolefin, and thermoplastic elastomers with the main components thereof, and more preferably soft polyvinyl chloride and polyolefin. In addition, it is more desirable to be a flexible container made of a material with a tensile modulus of 7N/mm 2 to 13N/mm 2 and a thickness of 0.2mm to 0.6mm. Tensile modulus of elasticity refers to the range of a linear relationship between tensile stress (load per unit area applied to the sample) and strain (elongation rate of the sample in the tensile direction) during a tensile test , The ratio of the tensile stress to the corresponding strain. In fact, it is based on JISK 7113 (Plastic Tensile Test Method), using an autograph (manufactured by Shimadzu Corporation, model AG-5KNI) and a force gauge (manufactured by Shimadzu Corporation, model SLBL) -500N) Perform a tensile test of the flexible container material. Use the data processing software "TRAPEZIUM" (manufactured by Shimadzu Corporation). Elastic modulus.

〔濾材〕 〔Filter material〕

濾材,為處理血液之部件,進一步具體而言,為從血液去除凝集物或白血球等之不期望成分的部件。濾材,至少包含過濾層X1及過濾層Y,理想係包含過濾層X1、過濾層X2及過濾層Y,更理想係僅由過濾層X1、過濾層X2及過濾層Y所構成。 The filter material is a member that processes blood, and more specifically, is a member that removes undesirable components such as agglutinates and leukocytes from the blood. The filter material includes at least a filter layer X1 and a filter layer Y, ideally includes a filter layer X1, a filter layer X2, and a filter layer Y, and more ideally is composed of only a filter layer X1, a filter layer X2, and a filter layer Y.

過濾層,包含過濾器構成單元。過濾器構成單元之數量為1之情形,其自體構成過濾層。過濾器構成單元之數量為2以上之情形,複數之過濾器構成單元積層而構成過濾層。過濾器構成單元之數量,係選擇而使過濾層具有指定的通氣阻力。 The filter layer contains the filter constituent units. When the number of filter constituent units is 1, it constitutes a filter layer by itself. When the number of filter constituent units is 2 or more, a plurality of filter constituent units are stacked to form a filter layer. The number of filter components is selected so that the filter layer has a specified ventilation resistance.

過濾層X1包含過濾器構成單元A1。過濾層X1,可在過 濾器構成單元A1之外,再包含進一步的過濾器構成單元,但理想係僅由1個以上的過濾器構成單元A1所構成。 The filter layer X1 includes a filter configuration unit A1. Filter layer X1, can be In addition to the filter configuration unit A1, further filter configuration units are included, but it is ideal to be constituted by only one or more filter configuration units A1.

過濾層X2包含過濾器構成單元A2。過濾層X2,可在過濾器構成單元A2之外,再包含進一步的過濾器構成單元,但理想係僅由1個以上的過濾器構成單元A2所構成。 The filter layer X2 includes a filter configuration unit A2. The filter layer X2 may include further filter structural units in addition to the filter structural unit A2, but it is ideally constituted by only one or more filter structural units A2.

過濾層Y包含過濾器構成單元B。過濾層Y,可在過濾器構成單元B之外,再包含進一步的過濾器構成單元,但理想係僅由1個以上的過濾器構成單元B所構成。 The filter layer Y includes a filter constituent unit B. The filter layer Y may include further filter structural units in addition to the filter structural unit B, but it is ideally constituted by only one or more filter structural units B.

過濾器構成單元之形狀,只要為具有可過濾血液之微孔、具有指定的通氣阻力者則無特別限定,但理想為由天然纖維、合成纖維、玻璃纖維等所成編布、織布、不織布等之纖維狀媒介、多孔膜、具有三維網眼狀連續孔之海綿狀構造物。 The shape of the filter constituent unit is not particularly limited as long as it has micropores that can filter blood and has a specified ventilation resistance, but it is ideally a woven, woven, or non-woven fabric made of natural fibers, synthetic fibers, glass fibers, etc. Such as fibrous media, porous membranes, sponge-like structures with three-dimensional mesh-like continuous pores.

過濾器構成單元之材料,只要為不易給予血球傷害者則無特別限定。過濾器構成單元之材料,例如,可列舉有機高分子材料、無機高分子材料、金屬等。其中有機高分子材料在切斷等之加工性上優異因此係理想。過濾器構成單元之具體材料,例如,可列舉聚酯、聚烯烴、聚丙烯腈、聚醯胺、聚苯乙烯、聚甲基丙烯酸甲酯、聚氟乙烯、聚氨酯、聚乙烯醇、聚乙烯縮醛、聚碸、聚偏氟乙烯、聚三氟氯乙烯、偏氟乙烯-四氟乙烯共聚物、聚醚碸、聚丙烯酸酯、丁二烯-丙烯腈共聚物、聚醚-聚醯胺嵌段共聚物、乙烯-乙烯醇共聚物、纖維素、乙酸纖維素等,理想為聚酯、聚烯烴,特別理想為聚酯。 The material of the filter constituent unit is not particularly limited as long as it is hard to inflict damage to blood cells. The material of the filter constituent unit includes, for example, organic polymer materials, inorganic polymer materials, metals, and the like. Among them, organic polymer materials are excellent in processing properties such as cutting and are therefore ideal. The specific materials of the filter constituent unit include, for example, polyester, polyolefin, polyacrylonitrile, polyamide, polystyrene, polymethyl methacrylate, polyvinyl fluoride, polyurethane, polyvinyl alcohol, and polyvinyl condensation. Aldehydes, polyvinylidene, polyvinylidene fluoride, polychlorotrifluoroethylene, vinylidene fluoride-tetrafluoroethylene copolymer, polyether turpentine, polyacrylate, butadiene-acrylonitrile copolymer, polyether-polyamide intercalation Segment copolymers, ethylene-vinyl alcohol copolymers, cellulose, cellulose acetate, etc. are preferably polyesters, polyolefins, and particularly preferably polyesters.

過濾器構成單元A1、過濾器構成單元A2、及過濾器構成 單元B之形狀,只要分別具有指定的通氣阻力,可為相同,亦可為相異。雖無特別限定,過濾器構成單元A1、過濾器構成單元A2、及過濾器構成單元B之形狀,理想為纖維狀媒介,進一步理想為不織布。 Filter structure unit A1, filter structure unit A2, and filter structure The shape of the unit B may be the same or different as long as they have specified ventilation resistances. Although not particularly limited, the shapes of the filter structural unit A1, the filter structural unit A2, and the filter structural unit B are desirably a fibrous medium, and more desirably a non-woven fabric.

過濾器構成單元A1、過濾器構成單元A2、及過濾器構成單元B之形狀之材料,只要分別具有指定的通氣阻力,可為相同,亦可為相異。雖無特別限定,過濾器構成單元A1、過濾器構成單元A2、及過濾器構成單元B之材料,理想為聚酯。 The material of the shape of the filter configuration unit A1, the filter configuration unit A2, and the filter configuration unit B may be the same or different as long as they have a specified ventilation resistance. Although not particularly limited, the material of the filter structural unit A1, the filter structural unit A2, and the filter structural unit B is preferably polyester.

過濾器構成單元A1之每單位厚度之通氣阻力,為5.0Pa.s/m2以上且未滿9.0Pa.s/m2,理想為5.0Pa.s/m2以上且未滿8.0Pa.s/m2。藉由使過濾器構成單元A1之每單位厚度之通氣阻力為上述範圍,即使過濾時濾材與出口部側之容器密接的情形下,過濾器構成單元A1內之流路仍可被維持,因此血流之流動不被阻礙,可獲得充足的過濾流速及過濾性能。本申請中,過濾器構成單元A1之每單位厚度之通氣阻力若未滿5.0Pa.s/m2,則無法得到充足的白血球去除性能,過濾後殘留白血球數會超過5.5Log。過濾器構成單元A1之每單位厚度之通氣阻力若為9.0Pa.s/m2以上,則無法得到充足的過濾流速,過濾時間會變為27分以上。 The ventilation resistance per unit thickness of the filter constituting unit A1 is 5.0Pa. s/m 2 or more and less than 9.0Pa. s/m 2 , ideally 5.0Pa. s/m 2 or more and less than 8.0Pa. s/m 2 . By making the ventilation resistance per unit thickness of the filter constituent unit A1 within the above range, even when the filter material is in close contact with the container on the outlet side during filtration, the flow path in the filter constituent unit A1 can be maintained. The flow of the stream is not hindered, and sufficient filtration flow rate and filtration performance can be obtained. In this application, if the ventilation resistance per unit thickness of the filter constituting unit A1 is less than 5.0Pa. s/m 2 , sufficient white blood cell removal performance cannot be obtained, and the number of residual white blood cells after filtration will exceed 5.5Log. If the ventilation resistance per unit thickness of the filter constituting unit A1 is 9.0Pa. s/m 2 or more, a sufficient filtration flow rate cannot be obtained, and the filtration time becomes 27 minutes or more.

過濾器構成單元A2之每單位厚度之通氣阻力,理想為5.0Pa.s/m2以上且未滿9.0Pa.s/m2,進一步理想為5.0Pa.s/m2以上且未滿8.0Pa.s/m2。藉由使過濾器構成單元A2之每單位厚度之通氣阻力為上述範圍,可在白血球去除性能、過濾速度上發揮優異性能。 The ventilation resistance per unit thickness of the filter constituting unit A2 is ideally 5.0Pa. s/m 2 or more and less than 9.0Pa. s/m 2 , more preferably 5.0Pa. s/m 2 or more and less than 8.0Pa. s/m 2 . By setting the ventilation resistance per unit thickness of the filter constituent unit A2 within the above-mentioned range, it is possible to exhibit excellent performance in terms of leukocyte removal performance and filtration speed.

過濾器構成單元B之每單位厚度之通氣阻力,為9.0Pa.s/m2以上,理想為9.0Pa.s/m2以上且未滿30.0Pa.s/m2,進一步理想為12.0 Pa.s/m2以上且未滿20.0Pa.s/m2。藉由使過濾器構成單元B之每單位厚度之通氣阻力為上述範圍,可在白血球去除性能上發揮優異性能。本申請中,過濾器構成單元B之每單位厚度之通氣阻力若未滿9.0Pa.s/m2,則無法得到充足的白血球去除性能,過濾後殘留白血球數會超過5.5Log。 The ventilation resistance per unit thickness of the filter constituting unit B is 9.0Pa. s/m 2 or more, ideally 9.0Pa. s/m 2 or more and less than 30.0Pa. s/m 2 , further preferably 12.0 Pa. s/m 2 or more and less than 20.0Pa. s/m 2 . By setting the ventilation resistance per unit thickness of the filter constituent unit B to the above range, it is possible to exhibit excellent performance in terms of leukocyte removal performance. In this application, if the ventilation resistance per unit thickness of the filter constituting unit B is less than 9.0Pa. s/m 2 , sufficient white blood cell removal performance cannot be obtained, and the number of residual white blood cells after filtration will exceed 5.5Log.

過濾層X1之通氣阻力,為4.0kPa.s/m以上且20.0kPa.s/m以下,理想為11.0kPa.s/m以上且未滿16.0kPa.s/m。藉由使過濾層X1之通氣阻力為上述範圍,可在白血球去除性能、過濾速度及血液回收上皆發揮優異性能。本申請中,過濾層X1之通氣阻力若未滿4.0kPa.s/m,即使為過濾器構成單元A1之適合設計,過濾器構成單元A1之量仍不足,導致無法得到充足的過濾流速,過濾時間會變為27分以上。此外,過濾層X1之通氣阻力若為20.0kPa.s/m以上,無法得到白血球去除性能,過濾後殘留白血球數會超過5.5Log,或過濾器內之殘留血量會增加,降低血液回收量。 The ventilation resistance of the filter layer X1 is 4.0kPa. s/m or more and 20.0kPa. s/m or less, ideally 11.0kPa. s/m or more and less than 16.0kPa. s/m. By setting the ventilation resistance of the filter layer X1 within the above range, excellent performance in terms of white blood cell removal performance, filtration speed, and blood recovery can be exerted. In this application, if the ventilation resistance of the filter layer X1 is less than 4.0kPa. s/m. Even if it is a suitable design for the filter constituent unit A1, the amount of the filter constituent unit A1 is still insufficient, resulting in the inability to obtain a sufficient filtration flow rate, and the filtration time will become more than 27 minutes. In addition, if the ventilation resistance of the filter layer X1 is 20.0kPa. Above s/m, the white blood cell removal performance cannot be obtained, and the number of residual white blood cells after filtration will exceed 5.5 Log, or the residual blood volume in the filter will increase, reducing the blood recovery volume.

過濾層X2之通氣阻力,理想為4.0kPa.s/m以上,進一步理想為11.0kPa.s/m以上且未滿16.0kPa.s/m。藉由使過濾層X2之通氣阻力為上述範圍,可在白血球去除性能、過濾速度上發揮優異性能。 The ventilation resistance of the filter layer X2 is ideally 4.0kPa. s/m or more, further preferably 11.0kPa. s/m or more and less than 16.0kPa. s/m. By setting the ventilation resistance of the filter layer X2 within the above-mentioned range, excellent performance in white blood cell removal performance and filtration speed can be exerted.

濾材之通氣阻力(構成濾材之全部過濾層之通氣阻力之合計),為55.0kPa.s/m以上且未滿75.0kPa.s/m,理想為60.0kPa.s/m以上且未滿67.0kPa.s/m。藉由使濾材之通氣阻力為上述範圍,可在適度之過濾速度下,發揮作為血液處理過濾器所被期待之白血球去除性能。本申請中,濾材之通氣阻力若未滿55.0kPa.s/m,即使前述過濾器構成單元A1、A2、B及前述過濾層X1、X2、Y為本申請所記載之設計,過濾流速仍會 變過高,無法得到充足的白血球去除性能,過濾後殘留白血球數會超過5.5Log。此外,濾材之通氣阻力若為75.0kPa.s/m以上,即使前述過濾器構成單元A1、A2、B及前述過濾層X1、X2、Y為本申請所記載之設計,過濾流速仍會過低,過濾時間會變為27分以上。 The air resistance of the filter material (the total air resistance of all filter layers constituting the filter material) is 55.0kPa. s/m or more and less than 75.0kPa. s/m, ideally 60.0kPa. s/m above and less than 67.0kPa. s/m. By setting the ventilation resistance of the filter material within the above-mentioned range, the leukocyte removal performance expected as a blood processing filter can be exhibited at a moderate filtration speed. In this application, if the ventilation resistance of the filter material is less than 55.0kPa. s/m, even if the aforementioned filter constituent units A1, A2, B and the aforementioned filter layers X1, X2, Y are designed as described in this application, the filtration flow rate will still be If it becomes too high, sufficient white blood cell removal performance cannot be obtained, and the number of residual white blood cells after filtration will exceed 5.5Log. In addition, if the ventilation resistance of the filter material is 75.0kPa. s/m or more, even if the aforementioned filter constituent units A1, A2, B and the aforementioned filter layers X1, X2, Y are designed as described in this application, the filtration flow rate will still be too low, and the filtration time will be 27 minutes or more.

本說明書中之「通氣阻力」(kPa.s/m),係在試樣(濾材、過濾層、或過濾器構成單元)通過一定流量之空氣時所產生的差壓被測定之值。通氣阻力,係藉由實施例所記載之方法測定。 The "ventilation resistance" (kPa·s/m) in this manual refers to the value measured when the sample (filter material, filter layer, or filter constituent unit) passes through a certain flow of air. The ventilation resistance was measured by the method described in the examples.

過濾器構成單元之「每單位厚度之通氣阻力」(Pa.s/m2),係為將過濾器構成單元之「通氣阻力」(kPa.s/m)除以過濾器構成單元之「厚度」(mm)的值。過濾器構成單元之「厚度」(mm),係藉由實施例所記載之方法測定。 The "ventilation resistance per unit thickness" (Pa·s/m 2 ) of the filter constituent unit is the "ventilation resistance" (kPa·s/m) of the filter constituent unit divided by the "thickness of the filter constituent unit""(Mm) value. The "thickness" (mm) of the filter constituent unit is measured by the method described in the examples.

控制過濾器構成單元之通氣阻力的方法並無特別限制,例如,過濾器構成單元為不織布之情形下,可藉由變化不織布之纖維徑或密度等,調節通氣阻力。不織布之基重或密度相同之情形下,藉由調細不織布之纖維徑,可提升例如比表面積,通氣阻力會變高。不織布之纖維徑相同之情形下,藉由提高密度,可縮小例如孔徑,通氣阻力會變高。 The method of controlling the ventilation resistance of the filter constituent unit is not particularly limited. For example, when the filter constituent unit is a non-woven fabric, the ventilation resistance can be adjusted by changing the fiber diameter or density of the non-woven fabric. When the basis weight or density of the non-woven fabric is the same, by fine-tuning the fiber diameter of the non-woven fabric, for example, the specific surface area can be increased, and the ventilation resistance will be higher. When the fiber diameter of the non-woven fabric is the same, by increasing the density, for example, the pore size can be reduced, and the ventilation resistance will increase.

不織布之纖維徑或密度,可基於不織布之製造條件從而調節。纖維構造之調節容易的不織布之製造方法,可列舉熔噴法。例如,可藉由探討樹脂黏度、熔融溫度、每單孔之吐出量、加熱氣體溫度、加熱氣體壓力、紡嘴與堆積網之距離等紡絲因素,獲得具有所期望之通氣阻力的不織布。此外,可基於習知資訊(例如,「不織布的基礎與應用」,P.119-127,平成5年8月25日發行,社團法人日本纖維機械協會等),藉由適宜 變更製造條件,製造具有適合通氣阻力的不織布。 The fiber diameter or density of the non-woven fabric can be adjusted based on the manufacturing conditions of the non-woven fabric. The manufacturing method of the non-woven fabric that is easy to adjust the fiber structure can be the melt-blown method. For example, by investigating spinning factors such as resin viscosity, melting temperature, discharge volume per single hole, heating gas temperature, heating gas pressure, and the distance between the spinning nozzle and the stacking net, a non-woven fabric with the desired ventilation resistance can be obtained. In addition, it can be based on conventional information (for example, "The basis and application of non-woven fabrics", P.119-127, issued on August 25, 2005, Japan Textile Machinery Association, etc.), by suitable Change the manufacturing conditions to manufacture non-woven fabrics with suitable ventilation resistance.

測定組裝於製品之濾材之過濾器構成單元的通氣阻力及厚度時,分解製品取出過濾器構成單元,測定各過濾器構成單元的通氣阻力及厚度。但測定厚度處,為距離過濾器構成單元之熔接部1cm以上之處。具體而言,在過濾面之周緣部附近,將濾材從容器切離,濾材為複數之過濾器構成單元所構成時,將其彼此剝開,得到各過濾器構成單元。製品中的過濾器構成單元,係與其他過濾器構成單元可分離式一體化。 When measuring the ventilation resistance and thickness of the filter component unit of the filter material assembled in the product, disassemble the product to take out the filter component unit, and measure the ventilation resistance and thickness of each filter component unit. However, the thickness is measured at a distance of 1 cm or more from the welded part of the filter unit. Specifically, when the filter material is cut away from the container near the peripheral edge of the filter surface, and the filter material is composed of a plurality of filter constituent units, they are peeled off each other to obtain each filter constituent unit. The filter constituent unit in the product is separable and integrated with other filter constituent units.

通氣阻力高,代表空氣不易通過。例如,濾材以纖維構成之情形中,即示意著纖維以緊密或均一之狀態纏繞。因此,血液不易流動,血球的阻塞增加,有處理速度降低的傾向。 High ventilation resistance means that the air is not easy to pass through. For example, when the filter material is composed of fibers, it means that the fibers are entangled in a tight or uniform state. Therefore, blood does not flow easily, clogging of blood cells increases, and the processing speed tends to decrease.

另一方面,通氣阻力低,代表空氣容易通過。例如,濾材以纖維構成之情形中,即示意著纖維以稀疏或不均一之狀態纏繞。因此,血液容易流動,與白血球之接觸次數減少,有白血球去除性能降低的傾向。 On the other hand, low ventilation resistance means that air is easy to pass through. For example, when the filter material is composed of fibers, it means that the fibers are entangled in a sparse or uneven state. Therefore, blood is easy to flow, the number of times of contact with white blood cells is reduced, and there is a tendency for the white blood cell removal performance to decrease.

藉由將通氣阻力相異之過濾器構成單元以特定之配置組合使用即可提升過濾速度及白血球去除性能的理由並非顯而易見。係推測若於流路確保部件之上流側,將具有特定特性之過濾器構成單元以特定之厚度配置,即使過濾時出口部側之可撓性容器朝濾材密接,仍不會減損濾材內之血液流路,可提高過濾流速。進一步地,係推測此有助於有效過濾面積提升,其結果係,即使為稀疏構造之過濾器構成單元,仍可發揮白血球去除能。然而,本發明並非藉此等推測機制所限定者。 It is not obvious that the filtering speed and the leukocyte removal performance can be improved by combining filter components with different ventilation resistances in a specific configuration. It is speculated that if the filter components with specific characteristics are arranged at a specific thickness on the upstream side of the flow path securing member, even if the flexible container on the outlet side is in close contact with the filter material during filtration, the blood in the filter material will not be degraded. The flow path can increase the filtration flow rate. Furthermore, it is inferred that this contributes to the increase of the effective filtration area. As a result, even if the filter constituent unit has a sparse structure, it can still exhibit the leukocyte removal performance. However, the present invention is not limited by this speculation mechanism.

本申請中,以前述過濾層X2、Y、流路確保部件之順序配置之設計,無法得到充足的過濾流速及白血球去除性能,過濾後殘留白血 球數超過5.5Log,過濾時間會變為27分以上。 In this application, the design of the aforementioned filter layers X2, Y, and flow path ensuring components are arranged in order, and sufficient filtration flow rate and white blood cell removal performance cannot be obtained, and white blood remains after filtration. If the number of balls exceeds 5.5Log, the filtering time will become more than 27 points.

〔流路確保部件〕 〔Parts for ensuring flow path〕

流路確保部件,係指所有配置於濾材與出口部間的部件。流路確保部件,只要可對濾材與出口部側之可撓性容器於過濾中之密接導致的血液流動之遮斷造成抑制,則無特別限定。流路確保部件,可列舉例如流路確保片材、過濾層等。此外,流路確保部件,可列舉例如用於防止濾材與容器間之密接而配置於此等之間的管(例如,參照歐洲專利第0526678號說明書)、設置於容器內面之凹凸部(日本專利特開平11-216179號公報)、插入濾材與容器之間的針織纖維製篩(國際公開第95/017236號手冊)、插入濾材與容器之間的可撓性框片材(國際公開第95/017236號手冊)等。 The flow path securing parts refer to all the parts arranged between the filter medium and the outlet part. The flow path securing member is not particularly limited as long as it can inhibit the blocking of blood flow caused by the close contact between the filter medium and the flexible container on the outlet side during filtration. The flow path securing member includes, for example, a flow path securing sheet, a filter layer, and the like. In addition, the flow path securing member includes, for example, a tube arranged between the filter medium and the container (for example, refer to the specification of European Patent No. 0526678) to prevent the close contact between the filter medium and the container, and the concave-convex part (Japanese Japanese Patent Laid-Open No. 11-216179), a knitted fiber sieve inserted between the filter material and the container (International Publication No. 95/017236 Manual), and a flexible frame sheet inserted between the filter material and the container (International Publication No. 95 /017236 Manual) and so on.

流路確保部件係過濾中在出口側可撓性容器與濾材之間不密接而形成連續空隙,有助於過濾流速之提升及有效過濾面積之提升。本申請中,未使用流路確保部件時,無法得到充足的過濾流速,過濾時間會變為27分以上,此外,有效過濾面積降低,白血球去除能變為5.5Log以上。 The flow path ensuring component is not tightly connected between the outlet side flexible container and the filter material in the filtration to form a continuous gap, which helps to increase the filtration flow rate and the effective filtration area. In this application, when the flow path ensuring component is not used, a sufficient filtration flow rate cannot be obtained, and the filtration time will be over 27 minutes. In addition, the effective filtration area is reduced, and the leukocyte removal energy can be over 5.5 Log.

流路確保部件,理想係包含含有過濾器構成單元P的過濾層Z。過濾層Z,除了過濾器構成單元P以外,可再含有進一步的過濾器構成單元,但理想係僅由1個以上的過濾器構成單元P所構成。 The flow path securing member desirably includes the filter layer Z including the filter constituent unit P. The filter layer Z may contain further filter structural units in addition to the filter structural unit P, but it is ideally constituted by only one or more filter structural units P.

過濾器構成單元P之形狀及材料,可列舉如上述〔濾材〕之項目中所記載者。過濾器構成單元P之形狀,理想為纖維狀媒介,更理想為不織布。過濾器構成單元P之材料,理想為聚酯。 The shape and material of the filter constituent unit P may be those described in the item of the above-mentioned [filter material]. The shape of the filter constituent unit P is preferably a fibrous medium, and more preferably a non-woven fabric. The material of the filter constituting unit P is preferably polyester.

過濾器構成單元P之每單位厚度之通氣阻力,理想為未滿0.5Pa.s/m2,進一步理想為0.1Pa.s/m2以上且未滿0.5Pa.s/m2。藉由使過濾 器構成單元P之每單位厚度之通氣阻力為上述範圍,可在過濾速度上發揮優異性能。 The ventilation resistance per unit thickness of the filter constituting unit P is ideally less than 0.5Pa. s/m 2 , more preferably 0.1Pa. s/m 2 or more and less than 0.5Pa. s/m 2 . By setting the ventilation resistance per unit thickness of the filter constituent unit P within the above-mentioned range, it is possible to exhibit excellent performance in terms of filtration speed.

過濾層Z之通氣阻力,理想為0.08kPa.s/m以上且0.16kPa.s/m以下,進一步理想為0.08kPa.s/m以上且0.12kPa.s/m以下。藉由使過濾層Z之通氣阻力為上述範圍,可減少濾材之量,而減少在血液處理過濾器內血液殘留之風險。 The ventilation resistance of the filter layer Z is ideally 0.08kPa. s/m or more and 0.16kPa. s/m or less, more preferably 0.08kPa. s/m or more and 0.12kPa. s/m or less. By setting the ventilation resistance of the filter layer Z within the above range, the amount of filter material can be reduced, and the risk of blood remaining in the blood processing filter can be reduced.

<血液處理過濾器之製造方法> <Manufacturing method of blood processing filter>

將經紡絲的過濾器構成單元A1及B分別積層,得到過濾層X1及Y,依序積層過濾層Y及X1以及流路確保部件。因應必要,積層過濾器構成單元A2,得到過濾層X2,積層使過濾層X2與過濾層Y鄰接。此積層體,可使用例如刃、超音波裁切機或雷射裁切機切斷為指定之尺寸從而作為濾材。 The spun filter constituent units A1 and B are layered, respectively, to obtain filter layers X1 and Y, and filter layers Y and X1 and flow path securing members are sequentially layered. If necessary, the layered filter constitutes the unit A2 to obtain the filter layer X2, and the layered filter layer X2 and the filter layer Y are adjacent to each other. The laminated body can be cut to a specified size using, for example, a blade, an ultrasonic cutting machine or a laser cutting machine to be used as a filter material.

濾材、流路確保部件與可撓性容器的一體化方法,無特別限定,可與以往的血液處理器同樣地一體化。例如,可如同以下說明,如同國際公開第2015/050216號之圖1~3所記載之血液處理過濾器(使用可撓性框作為流路確保部件)般地一體化。將具有入口部之可撓性容器、及具有出口部之可撓性容器,沿著濾材之周緣,在包夾濾材之狀態下帶狀密封而一體化。沿著濾材之周緣的此帶狀接著區域為內側密封部(第一密封部)。內側密封部,係設置為不包含濾材之周緣端部。比內側密封部更內側處,為血液流動之過濾部。 The method of integrating the filter medium, the flow path securing member, and the flexible container is not particularly limited, and it can be integrated in the same manner as in conventional blood processors. For example, as described below, the blood processing filter (using a flexible frame as a flow path securing member) described in Figs. 1 to 3 of International Publication No. 2015/050216 can be integrated. A flexible container with an inlet portion and a flexible container with an outlet portion are integrated along the periphery of the filter material in a band-shaped seal while sandwiching the filter material. This belt-shaped adhering area along the periphery of the filter material is the inner sealing part (first sealing part). The inner sealing part is set so as not to include the peripheral end of the filter material. The inner side than the inner sealing part is the filtering part through which the blood flows.

具有入口部之可撓性容器、及具有出口部之可撓性容器的周緣,被帶狀密封而一體化,其結果係,形成矩形環狀之外側密封部(第二 密封部)。又,內側密封部及外側密封部之形成,可利用高週波熔接,但並不限定於此。可使用超音波熔接、熱熔接等之各種接著技術。 The peripheral edge of the flexible container with the inlet portion and the flexible container with the outlet portion are sealed and integrated by a belt shape. As a result, a rectangular ring-shaped outer side sealing portion (second Sealing part). In addition, the formation of the inner sealing portion and the outer sealing portion can be welded by high-frequency welding, but it is not limited to this. Various bonding techniques such as ultrasonic welding and thermal welding can be used.

血液之入口與出口,亦可藉由射出成型等之方法預先與可撓性容器一體化形成,或者,可在擠壓成型之片材狀膜或圓柱狀之膜成型物形成孔洞或縫,其中,藉由個別射出成型或擠壓成型等所成型的入口用與出口用之部品,亦可藉由接著劑或熱密封或者高週波熔接等之習知技術,以液密且連通之狀態連接。基於蒸氣滅菌時不易發生容器變形、製造步驟容易的理由,後者為較理想。 The blood inlet and outlet can also be integrated with the flexible container in advance by injection molding or other methods. Alternatively, holes or slits can be formed in the extruded sheet-like film or cylindrical film-formed product, where The inlet and outlet parts molded by individual injection molding or extrusion molding can also be connected in a liquid-tight and connected state by conventional techniques such as adhesives, heat sealing, or high-frequency welding. The latter is more desirable for reasons that deformation of the container is less likely to occur during steam sterilization and the manufacturing steps are easy.

此外,於片材狀或圓柱狀之膜液密地裝上包含管狀物之入口用及出口用部品的情形,入口用及出口用之部品之材質,可於片材狀或圓柱狀之膜同材質,亦可為其他材質。為其他材質時,只要入口與出口可分別無空隙且液密地接合於片材狀或圓柱狀之膜,對操作性等不造成障礙,則材質上無特別限定。然而,藉由適於大量生產之熱密封或高週波熔接從而接合之情形,理想係與片材狀或圓柱狀之膜在熱及電性質上相近。 In addition, when the sheet-like or cylindrical membrane is liquid-tightly mounted with the inlet and outlet parts including the tube, the material of the inlet and outlet parts can be the same as the sheet-like or cylindrical membrane. The material can also be other materials. In the case of other materials, as long as the inlet and the outlet can be joined to a sheet-like or cylindrical film without gaps and liquid-tightly, and does not impede operability, etc., there is no particular limitation on the material. However, in the case of joining by heat sealing or high-frequency welding suitable for mass production, it is ideal to be similar in thermal and electrical properties to a sheet-like or cylindrical film.

如軟質聚氯乙烯之電容率較高之材料的情形,可藉由高週波熔接合適地接合;如聚烯烴之電容率較低之低熔點材料的情形,可藉由熱密封合適地接合。 For example, in the case of soft polyvinyl chloride with high permittivity materials, it can be properly joined by high frequency welding; for example, in the case of polyolefin with low permittivity materials, it can be properly joined by heat sealing.

實施例Example

以下,藉由實施例進一步詳細說明本發明,但本發明並非由以下之實施例限定者。 Hereinafter, the present invention will be described in further detail with examples, but the present invention is not limited by the following examples.

血液處理過濾器之物性及性能,藉由以下方法側定。 The physical properties and performance of blood processing filters are determined by the following methods.

(濾材、過濾層及過濾器構成單元之通氣阻力的測定) (Measurement of ventilation resistance of filter material, filter layer and filter unit)

於通氣性試驗裝置(KatoTech股份公司製,KES-F8-AP1)之通氣孔(通氣孔面積2πcm2(φ 1.414cm))上,載放5cm×20cm尺寸的試樣(濾材、過濾層、或過濾器構成單元),測定以8πcm3/s通氣空氣約10秒時所產生的壓力損失(kPa.s/m)(即以試樣區隔之兩側的壓力差),定為通氣阻力。 A vent hole in the air permeability test apparatus (KatoTech stock company system, KES-F8-AP1) of (vent area 2πcm 2 (φ 1.414cm)), placing the sample 5cm × 20cm size (filter, filter layer, or Filter constituent unit), measure the pressure loss (kPa·s/m) (the pressure difference between the two sides of the sample compartment) generated when air is ventilated at 8πcm 3 /s for about 10 seconds, and set it as the ventilation resistance.

(過濾器構成單元之厚度之測定) (Measurement of the thickness of the filter component)

從過濾器構成要素,切出5cm×20cm尺寸之試樣,將其載放於針盤厚度計(型號:G、製造商:尾崎製作所),測定其厚度(mm)。 Cut out a 5cm×20cm sample from the filter components, place it on a dial thickness gauge (model: G, manufacturer: Ozaki Seisakusho), and measure its thickness (mm).

(過濾器構成單元之每單位厚度之通氣阻力的測定) (Measurement of the ventilation resistance per unit thickness of the filter constituent unit)

將前述「(濾材、過濾層及過濾器構成單元之通氣阻力的測定)」所測定的過濾器構成單元之通氣阻力(kPa.s/m),除以前述「(過濾器構成單元之厚度之測定)」所測定的過濾器構成單元之厚度(mm),求出過濾器構成單元之每單位厚度之通氣阻力。 Divide the aeration resistance (kPa·s/m) of the filter constituent unit measured in the aforementioned "(Measurement of the ventilation resistance of the filter material, filter layer and filter constituent unit)" by the aforementioned "(The thickness of the filter constituent unit) Measurement)" The thickness (mm) of the measured filter constituent unit, and the ventilation resistance per unit thickness of the filter constituent unit is obtained.

(血液處理過濾器之白血球去除性能) (White blood cell removal performance of blood processing filter)

血液製劑,使用根據歐洲基準(the Guide to the Preparation,Use and Quality Assurance of Blood Components第19版(2017年))所製備的紅血球製劑,在落差110cm的落差下使用實施例、比較例之血液處裡過濾器過濾、回收,得到過濾後血液製劑。其中,落差係指紅血球製劑之流入過濾前袋之最下部至紅血球製劑之過濾後回收袋之最下部(圖1)。 The blood preparation used the erythrocyte preparation prepared according to the European standard (the Guide to the Preparation, Use and Quality Assurance of Blood Components 19th edition (2017)), and the blood of the Examples and Comparative Examples was used at a drop of 110 cm The inner filter is filtered and recovered to obtain the filtered blood preparation. Among them, the drop refers to the lowest part of the bag before the filtration of the red blood cell preparation to the lowest part of the recovery bag after the filtration of the red blood cell preparation (Figure 1).

接著,使用比頓狄金森公司(BD公司)製白血球數測定用套組「LeucoCOUNT」及BD公司製流式細胞儀FACS CantoII測定過濾後之血液製劑中的白血球濃度,根據以下算式,算出過濾後殘存白血球數(rWBC),作為血液處理過濾器之白血球去除性能之指標。 Next, the white blood cell concentration in the blood preparation after filtration was measured using the set "LeucoCOUNT" for measuring the number of white blood cells manufactured by Beaton Dickinson (BD) and the flow cytometer FACS Canto II manufactured by BD, and the concentration of white blood cells in the filtered blood preparation was calculated according to the following formula The number of remaining white blood cells (rWBC) is used as an indicator of the white blood cell removal performance of the blood processing filter.

rWBC=log(過濾後血液製劑中的白血球濃度×過濾後血液製劑之量) rWBC=log (the concentration of white blood cells in the blood preparation after filtration × the amount of blood preparation after filtration)

〔評價基準〕 [Evaluation criteria]

◎:未滿5.0 ◎: Less than 5.0

○:5.0以上且未滿5.5 ○: 5.0 or more but less than 5.5

×:5.5以上 ×: 5.5 or more

(過濾時間) (Filter time)

將前述「(血液處理過濾器之白血球去除性能)」中,從紅血球製劑開始流入血液處理過濾器至過濾後紅血球製劑之回收袋之質量增加停止所需時間(分)作為過濾時間(分)。又,回收袋之質量增加之停止,係指從過濾開始後每隔1分測定回收袋之質量下,回收袋之質量變化變為0.1g以下的時間點。本實施例中,係將判斷為質量增加之停止的最後1分包含於過濾時間而算出。 In the aforementioned "(White blood cell removal performance of blood processing filter)", the filtration time (minutes) is the time required for the red blood cell preparation to flow into the blood processing filter until the mass increase of the red blood cell preparation recovery bag stops after filtration (minutes). In addition, the cessation of the increase in the mass of the recovered bag refers to the point at which the change in the mass of the recovered bag becomes 0.1g or less when the quality of the recovered bag is measured every minute after the start of filtration. In the present embodiment, it is calculated by including the last minute of the stop judged as the mass increase in the filtering time.

〔評價基準〕 [Evaluation criteria]

◎:未滿24分 ◎: Less than 24 points

○:24分以上且未滿27分 ○: 24 points or more but less than 27 points

×:27分以上 ×: 27 points or more

(血液回收量) (Amount of blood recovered)

評價血液損失量(過濾前血液量與過濾後血液量之差)作為血液回收量之指標。藉由從裝入過濾前之紅血球製劑及紅血球保存液的袋套組之重量減去空狀態之同型態袋套組之重量,算出過濾前血液量。過濾後,將連接血液處理過濾器與回收袋之線路,從距離血液處理過濾器之出口5cm的地方切離。藉由從如此獲得之回收袋重量減去空狀態之同型態之回收袋重 量,算出過濾後血液。 The blood loss (the difference between the blood volume before filtration and the blood volume after filtration) is evaluated as an indicator of the blood recovery volume. The blood volume before filtration is calculated by subtracting the weight of the empty bag set of the same type from the weight of the bag set containing the red blood cell preparation and the red blood cell storage solution before filtration. After filtration, cut the line connecting the blood processing filter and the recovery bag at a distance of 5 cm from the outlet of the blood processing filter. By subtracting the weight of the same type of recycling bag in the empty state from the weight of the recycling bag thus obtained Calculate the filtered blood.

〔評價基準〕 [Evaluation criteria]

◎:未滿25ml ◎: Less than 25ml

○:25ml以上且未滿30ml ○: 25ml or more and less than 30ml

×:30ml以上 ×: more than 30ml

(實施例1~5) (Examples 1~5)

過濾器構成單元A1及過濾器構成單元B,使用以熔噴法製造的不織布。過濾器構成單元P,使用以紡絲粘合製造的不織布。 The filter configuration unit A1 and the filter configuration unit B use non-woven fabrics manufactured by the melt blown method. The filter constituent unit P uses a nonwoven fabric manufactured by spunbonding.

過濾器構成單元A1為厚度0.42(mm)、每單位厚度之通氣阻力5.2(Pa.s/m2)的PBT不織布;此外,過濾器構成單元B為厚度0.41(mm)、每單位厚度之通氣阻力10.4(Pa.s/m2)的PBT不織布;過濾器構成單元P為厚度0.20(mm)、每單位厚度之通氣阻力0.20(Pa.s/m2)的聚對苯二甲酸乙二酯不織布,分別以表1所示張數及順序重疊,成為積層體,使用雷射裁切機切斷為91cm×74cm之尺寸而製成濾材。 The filter constituent unit A1 is a PBT non-woven fabric with a thickness of 0.42 (mm) and a ventilation resistance per unit thickness of 5.2 (Pa·s/m 2 ); in addition, the filter constituent unit B is a thickness of 0.41 (mm) and ventilation per unit thickness PBT non-woven fabric with a resistance of 10.4 (Pa.s/m 2 ); the filter constituent unit P is a polyethylene terephthalate with a thickness of 0.20 (mm) and a ventilation resistance per unit thickness of 0.20 (Pa.s/m 2) The non-woven fabrics were stacked in the number and order shown in Table 1 to form a laminate, which was cut into a size of 91cm×74cm using a laser cutter to make a filter material.

將此濾材,包夾於具有成為血液之入口部或出口部之口的2張可撓性聚氯乙烯樹脂片材之間,使用高週波熔接機,熔接濾材與可撓性片材之周緣部分,使其一體化。又,熔接部之內測,為縱長尺寸為74mm、橫長尺寸為57mm、且角部分為曲線之長方形之有效過濾部分,有效過濾面積為42cm2。進一步熔接可撓性片材之周緣部分,使其一體化,製作血液處理過濾器。對該血液處理過濾器實施115℃、59分鐘的高壓蒸氣滅菌後,進行前述白血球去除性能試驗。 This filter material is sandwiched between two flexible polyvinyl chloride resin sheets that have the inlet or outlet of the blood. A high-frequency welding machine is used to weld the filter material and the peripheral part of the flexible sheet. , Make it integrated. In addition, the internal measurement of the welded part is a rectangular effective filtering part with a vertical dimension of 74mm, a horizontal dimension of 57mm, and a curved corner, with an effective filtering area of 42cm 2 . The peripheral part of the flexible sheet is further welded and integrated to produce a blood processing filter. After the blood processing filter was subjected to high-pressure steam sterilization at 115°C for 59 minutes, the aforementioned leukocyte removal performance test was performed.

(實施例6~10、15、17) (Examples 6-10, 15, 17)

除了過濾器構成單元A1改為使用厚度0.42(mm)、每單位厚度之通氣阻力7.3(Pa.s/m2)的PBT不織布以外,使用與實施例1同樣的方法,製作血液處理過濾器,進行白血球去除性能試驗。 Except that the filter constituent unit A1 was changed to a PBT non-woven fabric with a thickness of 0.42 (mm) and a ventilation resistance per unit thickness of 7.3 (Pa·s/m 2 ), the same method as in Example 1 was used to produce a blood processing filter. Perform a white blood cell removal performance test.

(實施例11~13) (Examples 11~13)

除了過濾器構成單元A1改為使用厚度0.42(mm)、每單位厚度之通氣阻力8.7(Pa.s/m2)的PBT不織布以外,使用與實施例1同樣的方法,製作血液處理過濾器,進行白血球去除性能試驗。 Except that the filter constituent unit A1 was changed to a PBT non-woven fabric with a thickness of 0.42 (mm) and a ventilation resistance per unit thickness of 8.7 (Pa·s/m 2 ), the same method as in Example 1 was used to produce a blood processing filter. Perform a white blood cell removal performance test.

(實施例14) (Example 14)

除了過濾器構成單元B改為使用厚度0.41(mm)、每單位厚度之通氣阻力12.7(Pa.s/m2)的PBT不織布以外,使用與實施例6同樣的方法,製作血液處理過濾器,進行白血球去除性能試驗。 Except that the filter component B was changed to a PBT non-woven fabric with a thickness of 0.41 (mm) and a ventilation resistance per unit thickness of 12.7 (Pa·s/m 2 ), the same method as in Example 6 was used to produce a blood processing filter. Perform a white blood cell removal performance test.

(實施例16、18) (Examples 16, 18)

過濾器構成單元A2,使用熔噴法製造的不織布。 The filter constituting unit A2 uses a non-woven fabric manufactured by the melt-blown method.

除了過濾器構成單元A2使用厚度0.42(mm)、每單位厚度之通氣阻力7.3(Pa.s/m2)的PBT不織布以外,使用與實施例14同樣的方法,製作血液處理過濾器,進行白血球去除性能試驗。 Except that a PBT non-woven fabric with a thickness of 0.42 (mm) and a ventilation resistance per unit thickness of 7.3 (Pa·s/m 2 ) was used for the filter constituent unit A2, the same method as in Example 14 was used to produce a blood processing filter and perform leukocytes. Removal performance test.

(實施例19) (Example 19)

過濾器構成單元A1及A2,以及過濾器構成單元B,使用熔噴法製造的不織布。流路確保部件,使用如國際公開第2015/050216號所記載的可撓性聚氯乙烯樹脂製之入口側框片材及出口側框片材。 The filter configuration units A1 and A2, and the filter configuration unit B use non-woven fabrics manufactured by the melt-blown method. As the flow path securing member, the inlet side frame sheet and outlet side frame sheet made of flexible polyvinyl chloride resin as described in International Publication No. 2015/050216 are used.

過濾器構成單元A1及A2,使用厚度0.42(mm)、每單位厚度之通氣阻力7.3(Pa.s/m2)的PBT不織布。過濾器構成單元B,使用厚度 0.41(mm)、每單位厚度之通氣阻力12.7(Pa.s/m2)的PBT不織布。過濾器構成單元A1及A2,以及過濾器構成單元B,以表3所示張數及順序重疊,成為積層體,使用雷射裁切機切斷為91cm×74cm之尺寸而製成濾材。 The filter constituent units A1 and A2 use PBT non-woven fabric with a thickness of 0.42 (mm) and a ventilation resistance of 7.3 (Pa·s/m 2) per unit thickness. The filter component B uses a PBT non-woven fabric with a thickness of 0.41 (mm) and a ventilation resistance per unit thickness of 12.7 (Pa·s/m 2 ). The filter configuration units A1 and A2, and the filter configuration unit B were stacked in the number and order shown in Table 3 to form a laminate, which was cut into a size of 91cm×74cm using a laser cutter to produce a filter material.

將此濾材,包夾於可撓性聚氯乙烯樹脂製之入口側框片材及出口側框片材之間,使用高週波熔接機,熔接濾材之周緣部分,使其一體化。又,熔接部之內測,為縱長尺寸為74mm、橫長尺寸為57mm、且角部分為曲線之長方形之有效過濾部分,有效過濾面積為42cm2。進一步將入口側框片材及出口側框片材包夾於具有成為血液之入口部或出口部之口的2張可撓性聚氯乙烯樹脂片材之間,使用高週波熔接機,熔接可撓性片材之周緣部分,使其一體化而製作血液處理過濾器。對該血液處理過濾器實施115℃、59分鐘的高壓蒸氣滅菌後,進行前述各種試驗。 This filter material is sandwiched between the inlet side frame sheet and the outlet side frame sheet made of flexible polyvinyl chloride resin, and the peripheral part of the filter material is welded and integrated using a high frequency welding machine. In addition, the internal measurement of the welded part is a rectangular effective filtering part with a vertical dimension of 74mm, a horizontal dimension of 57mm, and a curved corner, with an effective filtering area of 42cm 2 . Furthermore, the inlet side frame sheet and the outlet side frame sheet are sandwiched between two flexible polyvinyl chloride resin sheets that have ports that become the inlet or outlet of blood. The high-frequency welding machine is used for welding. The peripheral part of the flexible sheet is integrated to produce a blood processing filter. After the blood processing filter was subjected to high-pressure steam sterilization at 115°C for 59 minutes, the aforementioned various tests were performed.

(比較例1、2) (Comparative Examples 1, 2)

除了如表4所示將構成各過濾層之各過濾器構成單元之張數變更以外,以與實施例6~10同樣的方法評價。 The evaluation was performed in the same manner as in Examples 6 to 10, except that the number of sheets of each filter constituent unit constituting each filter layer was changed as shown in Table 4.

(比較例3、10) (Comparative Examples 3 and 10)

除了如表4或表5所示將構成各過濾層之各過濾器構成單元之張數變更以外,以與實施例14同樣的方法評價。 The evaluation was performed in the same manner as in Example 14, except that the number of sheets of each filter constituent unit constituting each filter layer was changed as shown in Table 4 or Table 5.

(比較例4) (Comparative Example 4)

除了如表4所示將構成各過濾層之各過濾器構成單元之張數變更以外,以與實施例15同樣的方法評價。 The evaluation was performed in the same manner as in Example 15 except that the number of sheets of each filter constituent unit constituting each filter layer was changed as shown in Table 4.

(比較例5) (Comparative Example 5)

除了如表4所示將構成各過濾層之各過濾器構成單元之張數變更以 外,以與實施例16同樣的方法評價。 Except as shown in Table 4, the number of sheets of each filter constituent unit constituting each filter layer is changed to Otherwise, the evaluation was carried out in the same manner as in Example 16.

(比較例6) (Comparative Example 6)

除了如表4所示將構成各過濾層之各過濾器構成單元之張數變更以外,以與實施例19同樣的方法評價。 The evaluation was carried out in the same manner as in Example 19, except that the number of sheets of each filter constituent unit constituting each filter layer was changed as shown in Table 4.

(比較例7) (Comparative Example 7)

如表5所示,過濾器構成單元A1,改為使用厚度0.42(mm)、每單位厚度之通氣阻力4.5(Pa.s/m2)的PBT不織布,除此以外,使用與實施例4同樣的方法,製成血液處過濾器,進行白血球去除性能試驗。 As shown in Table 5, the filter constituent unit A1 is replaced with a PBT non-woven fabric with a thickness of 0.42 (mm) and a ventilation resistance per unit thickness of 4.5 (Pa·s/m 2 ). Other than that, the same as in Example 4 is used. The method is to make a blood filter and perform a white blood cell removal performance test.

(比較例8) (Comparative Example 8)

如表5所示,過濾器構成單元A1,改為使用厚度0.42(mm)、每單位厚度之通氣阻力9.2(Pa.s/m2)的PBT不織布,除此以外,使用與實施例1同樣的方法,製成血液處過濾器,進行白血球去除性能試驗。 As shown in Table 5, the filter constituent unit A1 is replaced with a PBT non-woven fabric with a thickness of 0.42 (mm) and a ventilation resistance per unit thickness of 9.2 (Pa·s/m 2 ). Except for this, the same as in Example 1 is used. The method is to make a blood filter and perform a white blood cell removal performance test.

(比較例9、11、12) (Comparative Examples 9, 11, 12)

如表5所示,過濾器構成單元B為厚度0.41(mm)、每單位厚度之通氣阻力8.8(Pa.s/m2),且變更構成各過濾層之各過濾器構成單元的張數,除此以外,使用與實施例6~10同樣的方法評價。 As shown in Table 5, the filter component B has a thickness of 0.41 (mm) and a ventilation resistance per unit thickness of 8.8 (Pa·s/m 2 ), and the number of filter components constituting each filter layer is changed. Except for this, it evaluated using the same method as Examples 6-10.

(比較例13) (Comparative Example 13)

過濾器構成單元A2,以及過濾器構成單元B,使用熔噴法製造的不織布。 The filter configuration unit A2 and the filter configuration unit B use non-woven fabrics manufactured by the melt-blown method.

過濾器構成單元A2,使用厚度0.42(mm)、每單位厚度之通氣阻力7.3(Pa.s/m2)的PBT不織布。過濾器構成單元B,使用厚度0.41(mm)、每單位厚度之通氣阻力12.7(Pa.s/m2)的PBT不織布。過濾器構成單元A2,以 及過濾器構成單元B,以表5所示張數及順序重疊,成為積層體,使用雷射裁切機切斷為91cm×74cm之尺寸而製成濾材。 The filter constituent unit A2 uses a PBT non-woven fabric with a thickness of 0.42 (mm) and a ventilation resistance of 7.3 (Pa·s/m 2) per unit thickness. The filter component B uses a PBT non-woven fabric with a thickness of 0.41 (mm) and a ventilation resistance per unit thickness of 12.7 (Pa·s/m 2 ). The filter configuration unit A2 and the filter configuration unit B are stacked in the number and order shown in Table 5 to form a laminate, which is cut into a size of 91 cm×74 cm using a laser cutter to prepare a filter material.

將此濾材,以與實施例1同樣的方法製成血液處理過濾器,進行白血球去除性能試驗。 This filter material was made into a blood processing filter by the same method as in Example 1, and the leukocyte removal performance test was performed.

Figure 109127422-A0305-02-0027-1
Figure 109127422-A0305-02-0027-1

Figure 109127422-A0305-02-0028-2
Figure 109127422-A0305-02-0028-2

Figure 109127422-A0305-02-0029-3
Figure 109127422-A0305-02-0029-3

Figure 109127422-A0305-02-0030-4
Figure 109127422-A0305-02-0030-4

Figure 109127422-A0305-02-0031-5
Figure 109127422-A0305-02-0031-5

【產業利用性】【Industrial Utilization】

本發明之血液處理過濾器,可作為用於從含血液成分之液體或血液中去除凝集物或白血球等之不期望成分的血液處理過濾器使用。 The blood processing filter of the present invention can be used as a blood processing filter for removing undesired components such as agglutinates or leukocytes from liquid or blood containing blood components.

特別係,可用於從輸血用之全血製劑、紅血球製劑、血小板製劑、血漿製劑等去除為各種副作用之原因之微小凝集物或白血球的目的,作為拋棄式血液處理過濾器可適宜使用。 In particular, it can be used for the purpose of removing microaggregates or white blood cells that are the cause of various side effects from whole blood preparations, red blood cell preparations, platelet preparations, plasma preparations, etc. for blood transfusion, and can be suitably used as a disposable blood processing filter.

Claims (4)

一種血液處理過濾器,其係包含具有血液之入口部及出口部之可撓性容器、配置於前述可撓性容器內的前述入口部與前述出口部之間的濾材、及配置於前述可撓性容器內的前述濾材與前述出口部之間的流路確保部件,其特徵係前述濾材,包含包含過濾器構成單元A1之過濾層X1、包含過濾器構成單元B之過濾層Y;前述過濾層X1,配置於前述過濾層Y與前述流路確保部件之間;前述過濾器構成單元A1的每單位厚度之通氣阻力為5.0Pa.s/m2以上且未滿9.0Pa.s/m2;前述過濾器構成單元B的每單位厚度之通氣阻力為9.0Pa.s/m2以上;前述過濾層X1的通氣阻力為4.0kPa.s/m以上且20.0kPa.s/m以下;前述濾材的通氣阻力為55.0kPa.s/m以上且未滿75.0kPa.s/m。 A blood processing filter comprising a flexible container having an inlet and an outlet for blood, a filter material arranged between the inlet and the outlet in the flexible container, and a filter arranged in the flexible container The member for ensuring the flow path between the filter medium and the outlet portion in the sexual container is characterized in that the filter medium includes a filter layer X1 including a filter structural unit A1, a filter layer Y including a filter structural unit B; the aforementioned filter layer X1, arranged between the filter layer Y and the flow path ensuring member; the ventilation resistance per unit thickness of the filter constituting unit A1 is 5.0Pa. s/m 2 or more and less than 9.0Pa. s/m 2 ; The ventilation resistance per unit thickness of the aforementioned filter constituting unit B is 9.0Pa. s/m 2 or more; the ventilation resistance of the aforementioned filter layer X1 is 4.0kPa. s/m or more and 20.0kPa. s/m or less; the ventilation resistance of the aforementioned filter material is 55.0kPa. s/m or more and less than 75.0kPa. s/m. 如申請專利範圍第1項所記載之血液處理過濾器,其中,前述流路確保部件係包含包含過濾器構成單元P之過濾層Z;前述過濾器構成單元P的每單位厚度之通氣阻力係未滿0.5Pa.s/m2;前述過濾層Z之通氣阻力為0.08kPa.s/m以上且0.16kPa.s/m以下。 The blood processing filter described in the first item of the scope of patent application, wherein the flow path ensuring member includes a filter layer Z including a filter constituent unit P; the ventilation resistance per unit thickness of the filter constituent unit P is not Full 0.5Pa. s/m 2 ; The ventilation resistance of the aforementioned filter layer Z is 0.08kPa. s/m or more and 0.16kPa. s/m or less. 如申請專利範圍第2項所記載之血液處理過濾器,其中,前述過濾層Z 之通氣阻力為0.08kPa.s/m以上且0.12kPa.s/m以下。 Such as the blood processing filter described in item 2 of the scope of patent application, wherein the aforementioned filter layer Z The ventilation resistance is 0.08kPa. s/m or more and 0.12kPa. s/m or less. 如申請專利範圍第1~3項中任一項所記載之血液處理過濾器,其中,前述濾材係進一步包含含有過濾器構成單元A2之過濾層X2;前述過濾層X2,配置於前述入口部與前述過濾層Y之間;前述過濾器構成單元A2的每單位厚度之通氣阻力為5.0Pa.s/m2以上且未滿9.0Pa.s/m2;前述過濾層X2的通氣阻力為4.0kPa.s/m以上。 As for the blood processing filter described in any one of items 1 to 3 in the scope of the patent application, the filter material further includes a filter layer X2 containing a filter constituent unit A2; the filter layer X2 is disposed at the inlet and Between the aforementioned filter layers Y; the ventilation resistance per unit thickness of the aforementioned filter constituting unit A2 is 5.0Pa. s/m 2 or more and less than 9.0Pa. s/m 2 ; The ventilation resistance of the aforementioned filter layer X2 is 4.0kPa. s/m or more.
TW109127422A 2020-08-12 2020-08-12 Blood processing filter TWI743939B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW109127422A TWI743939B (en) 2020-08-12 2020-08-12 Blood processing filter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW109127422A TWI743939B (en) 2020-08-12 2020-08-12 Blood processing filter

Publications (2)

Publication Number Publication Date
TWI743939B true TWI743939B (en) 2021-10-21
TW202206130A TW202206130A (en) 2022-02-16

Family

ID=80782628

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109127422A TWI743939B (en) 2020-08-12 2020-08-12 Blood processing filter

Country Status (1)

Country Link
TW (1) TWI743939B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012039400A1 (en) * 2010-09-21 2012-03-29 旭化成メディカル株式会社 Blood processing filter and method for producing blood processing filter
TWI446939B (en) * 2008-04-14 2014-08-01 Asahi Kasei Medical Co Ltd The filter method for removing the filter material and the blood preparation
CN104487105A (en) * 2012-07-25 2015-04-01 旭化成医疗株式会社 Blood treatment filter, blood circuit, and blood treatment method
WO2016006574A1 (en) * 2014-07-07 2016-01-14 旭化成メディカル株式会社 Blood processing filter and method for producing blood processing filter

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI446939B (en) * 2008-04-14 2014-08-01 Asahi Kasei Medical Co Ltd The filter method for removing the filter material and the blood preparation
WO2012039400A1 (en) * 2010-09-21 2012-03-29 旭化成メディカル株式会社 Blood processing filter and method for producing blood processing filter
CN104487105A (en) * 2012-07-25 2015-04-01 旭化成医疗株式会社 Blood treatment filter, blood circuit, and blood treatment method
WO2016006574A1 (en) * 2014-07-07 2016-01-14 旭化成メディカル株式会社 Blood processing filter and method for producing blood processing filter

Also Published As

Publication number Publication date
TW202206130A (en) 2022-02-16

Similar Documents

Publication Publication Date Title
US8496833B2 (en) Leukocyte removal method
US7591954B2 (en) Method for removing leukocytes, leukocyte-removing filter and utilization thereof
US8900462B2 (en) Method for removing leukocyte and filter for use therein
US7655146B2 (en) Method for filtering blood or blood components using leukocyte-removing filter and filter device
CN107735116B (en) Filter member for blood treatment filter and blood treatment filter
JPWO2012090835A1 (en) Blood processing filter, blood circuit system, and centrifugation method
EP3241574B1 (en) Method of manufacturing a blood filter
JP5631731B2 (en) Blood treatment filter
TWI743939B (en) Blood processing filter
JP4965212B2 (en) Blood treatment filter
CN114080245B (en) Blood treatment filter
JP2008086353A (en) Blood treatment filter and blood treatment method
JP4986285B2 (en) Filtration method and apparatus for blood or blood components using leukocyte removal filter
JP2005237791A (en) Method and system for filtering blood
CN113164844B (en) Filter for filtration, container with filter, and method for removing foreign matter in cell suspension
JP2006158738A (en) Centrifugal method of leukoreduction system
JP2011235188A (en) Blood treatment filter